ArQule arqule.com

ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead product, in Phase 2 clinical development, is ARQ 197, an inhibitor of the c-MET receptor tyrosine kinase. The Company has also initiated Phase 1 clinical testing with ARQ 621, designed to inhibit the Eg5 kinesin motor ...Show all

ArQule is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are c...Show all

See All Exits Recent Exits

ArQule - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2003-09-05Cyclis PharmaceuticalsAcquired
2001-01-22Camitro CorporationAcquired
Chimeric TherapiesAcquired
See all 3 investments